Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications
Raj Kumar, Piyush Mehta, K. Ravi Shankar, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 11, pp. 2831-2855
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Eknath Kole, Krishna Jadhav, Nitin Shirsath, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 81, pp. 104261-104261
Closed Access | Times Cited: 43
Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives
Siyuan Peng, Wenhao Wang, Rui Zhang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 161-161
Open Access | Times Cited: 17
Engineering nanoliposomal tiotropium bromide embedded in a lactose-arginine carrier forming Trojan-particle dry powders for efficient pulmonary drug delivery: A combined approach of in vitro-3D printing and in silico-CFD modeling
Salar Salmanipour, Amin Sokhansanj, Nahideh Jafari, et al.
International Journal of Pharmaceutics (2025), pp. 125171-125171
Closed Access | Times Cited: 2
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
Zhaokui Jin, Qi Gao, Keke Wu, et al.
Advanced Drug Delivery Reviews (2023) Vol. 202, pp. 115111-115111
Closed Access | Times Cited: 35
Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers
Rudra Pangeni, Tuo Meng, Sagun Poudel, et al.
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122661-122661
Open Access | Times Cited: 33
Inhalable nanomedicine for lung cancer treatment
Shuiying Zhang, Rui Li, Tong Jiang, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 261-280
Open Access | Times Cited: 10
State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives
Gabriella Costabile, Gemma Conte, Susy Brusco, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 347-347
Open Access | Times Cited: 7
In Vitro Evaluation of Colistin Conjugated with Chitosan-Capped Gold Nanoparticles as a Possible Formulation Applied in a Metered-Dose Inhaler
Narumon Changsan, Apichart Atipairin, Poowadon Muenraya, et al.
Antibiotics (2024) Vol. 13, Iss. 7, pp. 630-630
Open Access | Times Cited: 6
Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications
Pranav Kumar Prabhakar, Navneet Khurana, Manish Vyas, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 451-451
Open Access | Times Cited: 16
Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis
Mengqin Guo, Tingting Peng, Chuanbin Wu, et al.
Bioengineering (2023) Vol. 10, Iss. 6, pp. 727-727
Open Access | Times Cited: 14
Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS)
Clarence T. Dhege, Pradeep Kumar, Yahya E. Choonara
International Journal of Pharmaceutics (2024) Vol. 657, pp. 124182-124182
Closed Access | Times Cited: 5
Clay minerals-based drug delivery systems for anti-tuberculosis drugs
Saeida Saadat, Deepak Rawtani, Garvita Parikh
Journal of Drug Delivery Science and Technology (2022) Vol. 76, pp. 103755-103755
Closed Access | Times Cited: 20
Optimizing Andrographolide from Sambiloto Leaves (Andrographis paniculata) Using Cyclodextrin Metal–Organic Frameworks for Targeted Pulmonary Delivery via a Metered Dose Inhaler: A Proof-Of-Concept Study
Muhammad Ammar Syauqi, Andi Iqbal Burhanuddin, Azzahra Putri Utami Muharam, et al.
Molecular Pharmaceutics (2025)
Closed Access
In vitro and in silico studies of the interaction between glucocorticoid drug mometasone furoate and model lung surfactant monolayer
Md. Zohurul Islam, Martyna Krajewska, Krystyna Prochaska, et al.
RSC Advances (2025) Vol. 15, Iss. 8, pp. 5951-5964
Open Access
Aerodynamics and deposition of lipid-based nanocarriers in the lungs
Mohammad Intakhab Alam, Hasan Ali, Md Akbar
Elsevier eBooks (2025), pp. 69-83
Closed Access
Pulmonary drug delivery of lipid-based formulations via nebulizers
Anas Islam, Ambareen Fatima Ahmed, Widhilika Singh, et al.
Elsevier eBooks (2025), pp. 449-490
Closed Access
Nano technology-based drug delivery systems and herbal medicine
Khushi S. Kathole, Pooja R. Hatwar, R.L. Bakal, et al.
Journal of Drug Delivery and Therapeutics (2025) Vol. 15, Iss. 3, pp. 133-141
Open Access
Integration of 3D-printed micromixers and spray drying for pulmonary delivery of antimicrobial microparticles
Brayan J. Anaya, Aytug Kara, Rafaela Raposo, et al.
International Journal of Pharmaceutics (2025), pp. 125493-125493
Closed Access
Intranasal and inhaled delivery systems for targeting circadian dysfunction in neurodegenerative disorders, perspective and future outlook
Rhearne C. Ryan, Mathew N. Leslie, Patrick He, et al.
Advanced Drug Delivery Reviews (2025), pp. 115575-115575
Open Access
Literature review: The role of particle size distribution in drug delivery
Ahmad Ainurofiq, Ardelia Abidah Suryanto, Bunga Seftya Beltiartono, et al.
Multidisciplinary Reviews (2025) Vol. 8, Iss. 9, pp. 2025269-2025269
Closed Access
Excipients for Novel Inhaled Dosage Forms: An Overview
Carol Yousry, Mimansa Goyal, Vivek Gupta
AAPS PharmSciTech (2024) Vol. 25, Iss. 2
Closed Access | Times Cited: 3
Development of a self-microemulsifying drug delivery system to deliver delamanid via a pressurized metered dose inhaler for treatment of multi-drug resistant pulmonary tuberculosis
Himanshu Paliwal, Titpawan Nakpheng, Pijush Paul, et al.
International Journal of Pharmaceutics (2024) Vol. 655, pp. 124031-124031
Closed Access | Times Cited: 3
Nanomedicines via the pulmonary route: a promising strategy to reach the target?
M Guérin, Élise Lepeltier
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 8, pp. 2276-2297
Closed Access | Times Cited: 3
Liposomes for drug delivery by localized routes of administration
Maria Kannavou, Evangelos Natsaridis, Athanassios Missirlis
Elsevier eBooks (2024), pp. 329-362
Closed Access | Times Cited: 3
Impact of Nebulization on the Physicochemical Properties of Polymer–Lipid Hybrid Nanoparticles for Pulmonary Drug Delivery
Andrea Gonsalves, Jyothi U. Menon
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5028-5028
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top